Complex HMO Fermentation With In-Medium Enzymatic Recycling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing complex human milk oligosaccharides (HMOs) face challenges such as high costs, complex chemical processes, enzymatic reaction mixtures, and difficulties in exporting HMOs from cells, leading to excess lactose interference and purification issues.

Innovation Solution

A hybrid method combining fermentation and enzymatic reactions in the fermentation medium, using genetically modified cells with side-product recycling and transglycosidase enzymes to produce complex HMOs, reducing the need for pure starting oligosaccharides and minimizing lactose levels.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If enzymatic synthesis is used to produce complex HMOs, then the HMOs can be produced with specific structures, but the reaction produces a mixture of donor, acceptor, third oligosaccharide and side-products requiring extensive purification

Engineering Contradiction:
Improvestructural specificity of HMOsVSAvoidpurification complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent combines the enzymatic synthesis reaction and the purification step into a single integrated system by expressing both the transglycosidase enzyme and the glycosidase enzyme in the same host cell. This allows the reaction mixture to be processed in situ, converting side-products back into substrates and simplifying purification while maintaining structural specificity.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The host cell performs self-purification by using the co-expressed glycosidase enzyme to convert side-products (lactose) back into substrates (galactose and glucose) within the cell. This self-service mechanism reduces the need for external purification steps while maintaining high product specificity.

Inventive Principle:
Principle #25Self-service

2Productivity

If separately produced and purified donor and acceptor substrates are used in enzymatic process, then the reaction can proceed efficiently, but the cost of the process increases

Engineering Contradiction:
Improveenzymatic reaction efficiencyVSAvoidprocess cost
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The host cell is engineered to perform multiple functions: producing the transglycosidase enzyme for synthesis, producing the glycosidase enzyme for side-product conversion, and metabolizing substrates. This multi-functionality eliminates the need for separate production and purification steps for donor and acceptor substrates, reducing costs while maintaining reaction efficiency.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The cell uses its own metabolic pathways to generate the required substrates (galactose and glucose) from side-products, eliminating the need for external provision of purified substrates. This self-service approach reduces manufacturing costs while maintaining productivity.

Inventive Principle:
Principle #25Self-service

3Stability of the object's composition

If side-product (lactose) is released from donor substrate in enzymatic process, then the reaction equilibrium is maintained, but extensive purification is required to remove the large amount of lactose

Engineering Contradiction:
Improvereaction equilibriumVSAvoidpurification complexity
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The patent converts the harmful side-product (lactose) into a beneficial substrate by expressing glycosidase enzyme that hydrolyzes lactose back into galactose and glucose. This allows the side-product to be reused in the reaction, maintaining equilibrium while eliminating the need for extensive purification.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The system implements a feedback loop where the glycosidase enzyme continuously converts accumulated lactose side-products back into substrates, which are then reused by the transglycosidase reaction. This feedback mechanism maintains reaction equilibrium while minimizing side-product accumulation and purification needs.

Inventive Principle:
Principle #23Feedback

4Productivity

If fermentation route is used for producing complex HMOs, then production can be scaled industrially, but the HMOs face challenges in exporting from the cell into the medium

Engineering Contradiction:
Improveindustrial scale productionVSAvoidcell export efficiency
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent extracts the synthesis reaction from the cell interior to the cell exterior by using cell surface display or secretion of the transglycosidase enzyme. This allows the complex HMO synthesis to occur outside the cell where export is not an issue, while still using the cell's metabolic pathways for substrate provision and maintaining industrial scalability.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for higher yields of complex HMOs with reduced costs and lactose levels, overcoming the challenges of enzymatic equilibrium and cell export issues, achieving nearly full conversion of substrates to desired oligosaccharides.

Implementation Method 1

an enzyme with transglycosidase activity to produce a third oligosaccharide

Methodology Applied
Scientific EffectEnzymatic transglycosylation: Enzyme

Implementation Method 2

cultivating a genetically modified cell capable of producing a first oligosaccharide in a culture medium which is supplied with a carbon source

Methodology Applied
Scientific EffectFermentation: Fermentation

Data Source

PatentUS20260062726A1Hybrid method for producing complex hmos
Publication Date: 2026.03.05 DSM IP ASSETS BV
  • US20260062726A1 patent drawing
  • US20260062726A1 patent drawing
  • US20260062726A1 patent drawing

AI summary

The present disclosure relates to a method for producing oligosaccharides where the method combines a fermentation process and an enzymatic reaction in the medium of the fermentation, thereby enabling the formation of the oligosaccharide in the fermentation medium of an ongoing fermentation. The method is in particular suitable for the generation of complex oligosaccharides.